COMP <GO>
TWST vs HALO // EV/EBITDA & P/E VALUATION
Twist Bioscience Corporation (NASDAQ) VS. Halozyme Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: TWST 4
— HALO 8
■ METRIC PARITY
LAST: $152.78 (-11.92%) • MKT CAP: $11.50B
valuation
—
LAST: $130.91 (-0.21%) • MKT CAP: $14.89B
valuation
35.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TWST VS. HALO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TWST | HALO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 94.20% | 83.60% | +10.60 | TWST | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.70% | 18.00% | -29.70 | HALO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 35.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.66% | 4.33% | -4.99 | HALO | /fcf-yield <GO> |
| Operating Margin | -4.20% | 33.60% | -37.80 | HALO | /operating-margins <GO> |
| Net Profit Margin | -2.40% | 22.70% | -25.10 | HALO | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | 37.60% | -21.10 | HALO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.11 | +20.89 | TWST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | HALO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.2 | 79.0 | -21.80 | HALO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.88 | +0.10 | TWST | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 39.5x | -18.50 | TWST | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.50B | $14.89B | -$3.39B | HALO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TWST REV | HALO REV | TWST GROSS % | HALO GROSS % | TWST FCF | HALO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $1.40B | — | 83.6% | -$75.6M | $644.6M |
| FY 2024 | $0 | $1.02B | — | 84.3% | -$69.2M | $468.4M |
| FY 2023 | $0 | $829.3M | — | — | -$142.5M | $351.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TWST // BETA 0.98
HALO // BETA 0.88